SCHEMBL13776268

SCHEMBL13776268

Cc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2C)cc1O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLH Q9Y253 7/20 0.82
▸ MEN1 O00255 8/20 0.61
▸ KMT2A Q03164 8/20 0.61
▸ CYP1A2 P05177 8/20 0.61
▸ CYP1A1 P04798 7/20 0.61
▸ CYP1B1 Q16678 7/20 0.61
▸ KDM4E B2RXH2 6/20 0.61
▸ CYP3A4 P08684 6/20 0.61
▸ ABCB1 P08183 6/20 0.61
▸ HSD17B10 Q99714 5/20 0.61
▸ POLB P06746 5/20 0.61
▸ RECQL P46063 5/20 0.61
▸ CYP2C9 P11712 5/20 0.61
▸ MAPT P10636 5/20 0.61
▸ CYP2D6 P10635 5/20 0.61
▸ XDH P47989 5/20 0.61
▸ FTO Q9C0B1 5/20 0.61
▸ ALOX15 P16050 4/20 0.61
▸ HIF1A Q16665 4/20 0.61
▸ APEX1 P27695 4/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13056253 0.92 POLH (0.78) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL824468 0.90 POLH (1.00) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL9288825 0.89 MEN1 (0.78) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL6140182 0.87 POLH (0.80) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL30819258 0.87 POLH (0.80) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL16682483 0.86 POLH (0.77) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL13780248 0.85 POLH (0.82) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL13552041 0.85 MEN1 (0.76) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL9733297 0.84 ABCB1 (0.76) POLHMEN1KMT2ACYP1A2CYP1A1
SCHEMBL12636895 0.83 CYP3A4 (0.74) POLHMEN1KMT2ACYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186110-A1 GUAVA EXTRACT OMNICA GMBH (DE) 2009-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186110-A1 GUAVA EXTRACT SMPD4, GBA3, DPP4 POLH 1425/4885MEN1 4716/4885KMT2A 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback